On Monday, $Abivax S.A. (ABVX.US)$ Shares surged nearly 15% at the opening, approaching the previous all-time high, currently trading at $131.59. According to reports, Eli Lilly and Co has initiated preliminary discussions with French authorities to explore a potential acquisition of biotechnology company Abivax. The report states that Eli Lilly held initial talks with the French Ministry of Finance in early December to assess whether the acquisition of Abivax would be subject to the country's foreign investment review regulations. Additionally, Eli Lilly discussed the possible participation of state-owned investor Bpifrance as a minority shareholder.
Abivax surges on heightened expectations of acquisition by Eli Lilly and Co.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Airstar Bank. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.